127 related articles for article (PubMed ID: 26372412)
1. Stochastic Pharmacokinetic-Pharmacodynamic Analysis of the Effect of Transdermal Buprenorphine on Electroencephalogram and Analgesia.
Olesen AE; Olofsen E; Andresen T; Graversen C; Drewes AM; Dahan A
Anesth Analg; 2015 Nov; 121(5):1165-75. PubMed ID: 26372412
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models.
Andresen T; Upton RN; Foster DJ; Christrup LL; Arendt-Nielsen L; Drewes AM
Basic Clin Pharmacol Toxicol; 2011 Apr; 108(4):274-84. PubMed ID: 21138531
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
4. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
5. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Sorge J; Sittl R
Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.
Koltzenburg M; Pokorny R; Gasser UE; Richarz U
Pain; 2006 Dec; 126(1-3):165-74. PubMed ID: 16901645
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled study on the effect of buprenorphine and fentanyl on descending pain modulation: a human experimental study.
Arendt-Nielsen L; Andresen T; Malver LP; Oksche A; Mansikka H; Drewes AM
Clin J Pain; 2012 Sep; 28(7):623-7. PubMed ID: 22156892
[TBL] [Abstract][Full Text] [Related]
9. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
Mitra F; Chowdhury S; Shelley M; Williams G
Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
[TBL] [Abstract][Full Text] [Related]
10. Objective markers of the analgesic response to morphine in experimental pain research.
Brokjær A; Olesen AE; Kreilgaard M; Graversen C; Gram M; Christrup LL; Dahan A; Drewes AM
J Pharmacol Toxicol Methods; 2015; 73():7-14. PubMed ID: 25659520
[TBL] [Abstract][Full Text] [Related]
11. Dose-Dependent Flux of Buprenorphine Following Transdermal Administration in Healthy Subjects.
Wang Y; Cipriano A; Munera C; Harris SC
J Clin Pharmacol; 2016 Oct; 56(10):1263-71. PubMed ID: 26865472
[TBL] [Abstract][Full Text] [Related]
12. A novel approach to pharmaco-EEG for investigating analgesics: assessment of spectral indices in single-sweep evoked brain potentials.
Gram M; Graversen C; Nielsen AK; Arendt-Nielsen T; Mørch CD; Andresen T; Drewes AM
Br J Clin Pharmacol; 2013 Dec; 76(6):951-63. PubMed ID: 23521205
[TBL] [Abstract][Full Text] [Related]
13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study.
Steiner DJ; Sitar S; Wen W; Sawyerr G; Munera C; Ripa SR; Landau C
J Pain Symptom Manage; 2011 Dec; 42(6):903-17. PubMed ID: 21945130
[TBL] [Abstract][Full Text] [Related]
15. Transdermal buprenorphine in the treatment of chronic pain.
Sittl R
Expert Rev Neurother; 2005 May; 5(3):315-23. PubMed ID: 15938664
[TBL] [Abstract][Full Text] [Related]
16. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of buprenorphine from crushed and whole buprenorphine (subutex) tablets.
Simojoki K; Lillsunde P; Lintzeris N; Alho H
Eur Addict Res; 2010; 16(2):85-90. PubMed ID: 20130408
[TBL] [Abstract][Full Text] [Related]
18. A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain.
Ripa SR; McCarberg BH; Munera C; Wen W; Landau CJ
Expert Opin Pharmacother; 2012 Jun; 13(9):1229-41. PubMed ID: 22409388
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of transdermal buprenorphine patch in the elderly.
Al-Tawil N; Odar-Cederlöf I; Berggren AC; Johnson HE; Persson J
Eur J Clin Pharmacol; 2013 Feb; 69(2):143-9. PubMed ID: 22706617
[TBL] [Abstract][Full Text] [Related]
20. IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG).
Mouraux A; Bloms-Funke P; Boesl I; Caspani O; Chapman SC; Di Stefano G; Finnerup NB; Garcia-Larrea L; Goetz M; Kostenko A; Pelz B; Pogatzki-Zahn E; Schubart K; Stouffs A; Truini A; Tracey I; Troconiz IF; Van Niel J; Vela JM; Vincent K; Vollert J; Wanigasekera V; Wittayer M; Phillips KG; Treede RD
Trials; 2021 Jun; 22(1):404. PubMed ID: 34140041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
